Dana-Farber Cancer Institute at St. Elizabeth's Medical Center — Brighton, Massachusetts

Dana-Farber Cancer Institute at St. Elizabeth's Medical Center is a clinical research site located in Brighton, Massachusetts, United States 02135.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana-Farber Cancer Institute at St. Elizabeth's Medical Center has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Gastrointestinal Cancer, Hematologic Cancer, Thoracic Cancer.

Sponsors: Nadine McCleary, MD, MPH, Dana-Farber Cancer Institute.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana-Farber Cancer Institute at St. Elizabeth's Medical Center?

Dana-Farber Cancer Institute at St. Elizabeth's Medical Center has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana-Farber Cancer Institute at St. Elizabeth's Medical Center conducted?

Dana-Farber Cancer Institute at St. Elizabeth's Medical Center has 3 clinical trials on record, with 2 currently active. Their work covers Gastrointestinal Cancer, Hematologic Cancer, Thoracic Cancer.

Is Dana-Farber Cancer Institute at St. Elizabeth's Medical Center accredited by Crixeo Health?

Dana-Farber Cancer Institute at St. Elizabeth's Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana-Farber Cancer Institute at St. Elizabeth's Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.